Medicare Enrolled

Dr. Andrew Alloy, DO

Gastroenterology · Voorhees, NJ
2301 EVESHAM ROAD, Voorhees, NJ 08043
8567721600
Registered in NPPES since 2005
NPI: 1275533036 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alloy from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alloy? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alloy

Dr. Andrew Alloy is a gastroenterology specialist in Voorhees, NJ, with 21 years of NPI registration.

Between the years covered by Open Payments, Dr. Alloy received a total of $7,836 from 33 pharmaceutical and/or device companies across 718 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alloy is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years of NPI registration $7,836 industry payments

Industry Payment Transparency

Open Payments through 2023 ↗
$7,836
Total received (2018-2023)
Avg $1,306/year across 6 years
Top 16% in NJ for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
718
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$15
2022
$1,399
2021
$2,426
2020
$1,390
2019
$1,296
2018
$1,312

Payments by company (2023)

Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 100.0% of 2023 payments
All-time payments by company (2018-2023) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$2,921
Takeda Pharmaceuticals U.S.A., Inc.
$987
Janssen Biotech, Inc.
$490
QOL Medical, LLC
$470
AbbVie, Inc.
$460
AbbVie Inc.
$413
ABBVIE INC.
$408
Celgene Corporation
$277
Synergy Pharmaceuticals Inc
$267
Ironwood Pharmaceuticals, Inc
$142
Gilead Sciences, Inc.
$134
Ferring Pharmaceuticals Inc.
$96
Braintree Laboratories, Inc.
$78
UCB, Inc.
$73
IRONWOOD PHARMACEUTICALS, INC
$61
Allergan Inc.
$60
PFIZER INC.
$59
Intercept Pharmaceuticals, Inc.
$56
Alfasigma USA, Inc.
$52
Regeneron Healthcare Solutions, Inc.
$48
Romark Laboratories, LC
$45
RedHill Biopharma Inc.
$41
Nestle HealthCare Nutrition Inc.
$29
Endo Pharmaceuticals Inc.
$24
Daiichi Sankyo Inc.
$23
Dova Pharmaceuticals
$23
Cumberland Pharmaceuticals, Inc.
$16
Allergan, Inc.
$16
Medtronic, Inc.
$15
GlaxoSmithKline, LLC.
$15
Alexion Pharmaceuticals, Inc.
$14
Merck Sharp & Dohme Corporation
$14
Aries Pharmaceuticals, Inc.
$11
Top 3 companies account for 56.1% of all-time payments
Associated products mentioned in payments ›
APRISO · Alinia · Alinia Tablets 500mg 30 count bottle · Amitiza · CIMZIA · CLENPIQ · CREON · Cimzia · Creon · DUPIXENT · Dexilant · Doptelet · ELEVIEW · ENTYVIO · Entyvio · GI GENIUS · HUMIRA · Humira · INJECTAFER · Kanuma · LINZESS · Linzess · MAVYRET · MOTEGRITY · MOVIPREP · Mavyret · Movantik · NASCOBAL · OCALIVA · Omeclamox · REMICADE · RENFLEXIS · RINVOQ · SKYRIZI · STELARA · SUCRAID · SUPREP BOWEL PREP · SUTAB · Sucraid · TRELEGY ELLIPTA · TRULANCE · Talicia · Trulance · VIBERZI · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA · Zelnorm
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a gastroenterology specialist in Voorhees?
Compare gastroenterologists in the Voorhees area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists in nearby ZIP areas
377
County median income
$86,384
Nearest hospital to ZIP centroid (approximate)
WEST JERSEY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2023
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Alloy is a gastroenterology specialist, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Alloy receive payments from pharmaceutical companies?
Yes. Dr. Alloy received a total of $7,836 from 33 companies across 718 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Alloy) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →